Circumvent® PCV-M G2 is for use in healthy swine as young as 3 days as an aid in the prevention of viremia, aid in the reduction of lymphoid infection caused by PCV2, and an aid in the reduction of lung lesions caused by Mycoplasma hyopneumoniae. The only PCV2 vaccine approved for use in pigs as early as 3 days.
For use in healthy swine as an aid in the prevention of viremia, aid in the reduction of virus
shedding and aid in the reduction of lymphoid infection caused by porcine circovirus type 2 (PCV
2), and as an aid in the reduction of lung lesions due to Mycoplasma hyopneumoniae. PCV 2 efficacy
for at least 20 weeks following completion of vaccination has been demonstrated.
ADMINISTRATION and DOSAGE OPTIONS: Allow the vaccine to reach an ambient temperature of 16°- 27° C
(60°- 80° F) and shake well prior to use. Use aseptic technique. OPTION 1: Vaccinate pigs
intramuscularly at 3 weeks of age or older with a single 2 mL dose. OPTION 2: Vaccinate pigs
intramuscularly as early as 3-5 days of age with a 1 mL dose followed by a second 1 mL dose 3 weeks
CAUTIONS: Store at 2°-7°C (35°-45°F). Do not freeze. Use entire contents when first opened; do not
save partial contents. Burn the container and all unused product. Use only in healthy swine. Do not
vaccinate within 21 days before slaughter. The vaccine may induce significant localized adverse
reactions, particularly following booster vaccination. Localized reactions resolve 1-35 days
following vaccination. If allergic reaction
occurs, treat with epinephrine. Caution should be used to
avoid injecting your own fingers, hands, or other body parts. Accidental
injection can cause serious local reactions. Contact a physician immediately.
PRESERVATIVES: Gentamicin and thimerosal.
Circumvent® PCV-M G2 is for use in...